Skip to main content
. 2020 Jul 27;8(1):e001292. doi: 10.1136/bmjdrc-2020-001292

Table 2.

Univariate analysis of median change in HbA1c between 2016 and following flash monitoring prescription (mmol/mol and %)

Change in HbA1c n P value
Male −2 (−8–4) 900
−0.2 (−0.7–0.4)
Female −1 (− 8–6) 900 0.015
−0.1 (−0.7–0.6)
CSII −1 (−6–4) 1360
−0.1 (−0.6–0.4)
MDI −1 (−9–5) 440 0.246
−0.1 (−0.8–0.5)
SIMD quintile 1 +1 (−8–8) 145
+0.1 (−0.7–0.7)
SIMD quintile 2–5 −1 (−8–5) 1611 0.021
−0.1 (−0.7–0.5)
Early flash monitoring start −2 (−8–4) 751
−0.2 (−0.7–0.4)
Later flash monitoring start −1 (−8–6) 1049 0.013
−0.1 (−0.7–0.6)
HbA1c on target at baseline (<58 mmol/mol (7.5%)) +2 (−2–8) 613
+0.2 (−0.2–0.7)
HbA1c above target at baseline (≥58 mmol/mol (7.5%)) −4 (−11–2) 1187 <0.001
−0.4 (−1.0–0.2)
DAFNE −2 (−8–4) 644
−0.2 (−0.7–0.4)
No DAFNE −1 (−8–5) 1156 0.033
−0.1 (−0.7–0.5)
Two sensors or more collected per month −2 (−8–4) 1535
−0.2 (−0.7–0.4)
Fewer than two sensors collected per month +1 (−8–7) <0.001
+0.1 (−0.7–0.6) 265

Data are median (IQR).

CSII, continuous subcutaneous insulin infusion; DAFNE, Dose Adjustment for Normal Eating; HbA1c, hemoglobin A1c; MDI, multiple daily injection; SIMD, Scottish Index of Multiple Deprivation.